These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 10550147

  • 1. Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules.
    Gasbarri A, Martegani MP, Del Prete F, Lucante T, Natali PG, Bartolazzi A.
    J Clin Oncol; 1999 Nov; 17(11):3494-502. PubMed ID: 10550147
    [Abstract] [Full Text] [Related]

  • 2. Galectin-3 and CD44v6 as markers for preoperative diagnosis of thyroid cancer by RT-PCR.
    Samija I, Mateša N, Lukač J, Kusić Z.
    Diagn Mol Pathol; 2011 Dec; 20(4):233-41. PubMed ID: 22089351
    [Abstract] [Full Text] [Related]

  • 3. [Significance of galectin-3 and CD44v6 expression in differential diagnosis of thyroid nodules].
    Wang LH, Zhao YJ, Wang XY, Yuan P, Xu WQ, Xiao JC, Xu JP, Luo BR.
    Zhonghua Zhong Liu Za Zhi; 2005 Sep; 27(9):547-50. PubMed ID: 16438854
    [Abstract] [Full Text] [Related]

  • 4. Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions.
    Bartolazzi A, Gasbarri A, Papotti M, Bussolati G, Lucante T, Khan A, Inohara H, Marandino F, Orlandi F, Nardi F, Vecchione A, Tecce R, Larsson O, Thyroid Cancer Study Group.
    Lancet; 2001 May 26; 357(9269):1644-50. PubMed ID: 11425367
    [Abstract] [Full Text] [Related]

  • 5. Galectin-3 and CD44v6 positivity by RT-PCR method in fine needle aspirates of benign thyroid lesions.
    Matesa N, Samija I, Kusić Z.
    Cytopathology; 2007 Apr 26; 18(2):112-6. PubMed ID: 17397496
    [Abstract] [Full Text] [Related]

  • 6. Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study.
    Bartolazzi A, Orlandi F, Saggiorato E, Volante M, Arecco F, Rossetto R, Palestini N, Ghigo E, Papotti M, Bussolati G, Martegani MP, Pantellini F, Carpi A, Giovagnoli MR, Monti S, Toscano V, Sciacchitano S, Pennelli GM, Mian C, Pelizzo MR, Rugge M, Troncone G, Palombini L, Chiappetta G, Botti G, Vecchione A, Bellocco R, Italian Thyroid Cancer Study Group (ITCSG).
    Lancet Oncol; 2008 Jun 26; 9(6):543-9. PubMed ID: 18495537
    [Abstract] [Full Text] [Related]

  • 7. Galectin-3: presurgical marker of thyroid follicular epithelial cell-derived carcinomas.
    Saggiorato E, Aversa S, Deandreis D, Arecco F, Mussa A, Puligheddu B, Cappia S, Conticello S, Papotti M, Orlandi F.
    J Endocrinol Invest; 2004 Apr 26; 27(4):311-7. PubMed ID: 15233548
    [Abstract] [Full Text] [Related]

  • 8. Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms.
    Inohara H, Honjo Y, Yoshii T, Akahani S, Yoshida J, Hattori K, Okamoto S, Sawada T, Raz A, Kubo T.
    Cancer; 1999 Jun 01; 85(11):2475-84. PubMed ID: 10357421
    [Abstract] [Full Text] [Related]

  • 9. Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules.
    Abd-El Raouf SM, Ibrahim TR.
    Pathol Res Pract; 2014 Dec 01; 210(12):971-8. PubMed ID: 25041837
    [Abstract] [Full Text] [Related]

  • 10. Immunostaining of galectin-3 and CD44v6 using fine-needle aspiration for distinguishing follicular carcinoma from adenoma.
    Maruta J, Hashimoto H, Yamashita H, Yamashita H, Noguchi S.
    Diagn Cytopathol; 2004 Dec 01; 31(6):392-6. PubMed ID: 15540177
    [Abstract] [Full Text] [Related]

  • 11. Determination of galectin-3 messenger ribonucleic Acid overexpression in papillary thyroid cancer by quantitative reverse transcription-polymerase chain reaction.
    Bernet VJ, Anderson J, Vaishnav Y, Solomon B, Adair CF, Saji M, Burman KD, Burch HB, Ringel MD.
    J Clin Endocrinol Metab; 2002 Oct 01; 87(10):4792-6. PubMed ID: 12364475
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic utility of galectin-3 in aspirates of thyroid follicular lesions.
    Kim MJ, Kim HJ, Hong SJ, Shong YK, Gong G.
    Acta Cytol; 2006 Oct 01; 50(1):28-34. PubMed ID: 16514837
    [Abstract] [Full Text] [Related]

  • 13. Large needle aspiration biopsy and galectin-3 determination in selected thyroid nodules with indeterminate FNA-cytology.
    Carpi A, Naccarato AG, Iervasi G, Nicolini A, Bevilacqua G, Viacava P, Collecchi P, Lavra L, Marchetti C, Sciacchitano S, Bartolazzi A.
    Br J Cancer; 2006 Jul 17; 95(2):204-9. PubMed ID: 16804521
    [Abstract] [Full Text] [Related]

  • 14. Diagnostic utility of galectin-3 and CD26/DPPIV as preoperative diagnostic markers for thyroid nodules.
    Aratake Y, Umeki K, Kiyoyama K, Hinoura Y, Sato S, Ohno A, Kuribayashi T, Hirai K, Nabeshima K, Kotani T.
    Diagn Cytopathol; 2002 Jun 17; 26(6):366-72. PubMed ID: 12112826
    [Abstract] [Full Text] [Related]

  • 15. [Expression and clinical significance of galectin-3 in well-differentiated thyroid carcinoma].
    Ouyang D, Chen FJ, Wei MW, Yang AK, Chen ZQ, Li QL, Chen YF.
    Ai Zheng; 2005 Nov 17; 24(11):1367-71. PubMed ID: 16552965
    [Abstract] [Full Text] [Related]

  • 16. Molecular classification of thyroid nodules by cytology.
    Pagedar NA, Chen DH, Wasman JK, Savvides P, Schluchter MD, Wilhelm SM, Lavertu P.
    Laryngoscope; 2008 Apr 17; 118(4):692-6. PubMed ID: 18094649
    [Abstract] [Full Text] [Related]

  • 17. Serum galectin-1 and galectin-3 levels in benign and malignant nodular thyroid disease.
    Saussez S, Glinoer D, Chantrain G, Pattou F, Carnaille B, André S, Gabius HJ, Laurent G.
    Thyroid; 2008 Jul 17; 18(7):705-12. PubMed ID: 18630998
    [Abstract] [Full Text] [Related]

  • 18. Galectin-3 messenger ribonucleic acid and protein are expressed in benign thyroid tumors.
    Martins L, Matsuo SE, Ebina KN, Kulcsar MA, Friguglietti CU, Kimura ET.
    J Clin Endocrinol Metab; 2002 Oct 17; 87(10):4806-10. PubMed ID: 12364477
    [Abstract] [Full Text] [Related]

  • 19. Hexokinase III, cyclin A and galectin-3 are overexpressed in malignant follicular thyroid nodules.
    Hooft L, van der Veldt AA, Hoekstra OS, Boers M, Molthoff CF, van Diest PJ.
    Clin Endocrinol (Oxf); 2008 Feb 17; 68(2):252-7. PubMed ID: 17868400
    [Abstract] [Full Text] [Related]

  • 20. From the bench to the bedside. Galectin-3 immunodetection for improving the preoperative diagnosis of the follicular thyroid nodules.
    Gasbarri A, Marchetti C, Iervasi G, Bottoni A, Nicolini A, Bartolazzi A, Carpi A.
    Biomed Pharmacother; 2004 Feb 17; 58(6-7):356-9. PubMed ID: 15271416
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.